Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery

Clinical trial NCT04585620 · UNKNOWN

Trial details

NCT number: NCT04585620
Sponsor: Allan Vestergaard Danielsen, MD
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Pain Post-thoracotomy Pain Syndrome Pain, Neuropathic Pain, Postoperative

Start date: 2022-09-01
Primary completion: 2023-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.